Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Alopecia
ADR ID BADD_A00152
ADR Hierarchy
23      Skin and subcutaneous tissue disorders
23.02      Skin appendage conditions
23.02.02      Alopecias
23.02.02.001      Alopecia
Description A disorder characterized by a decrease in density of hair compared to normal for a given individual at a given age and body location. [CTCAE] Absence of hair from areas where it is normally present. [MeSH]
MedDRA Code 10001760
MeSH ID D000505
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Accelerated hair loss | Alopecia | Alopecia reversible | Alopecia, unspecified | Atrichia | Atrichosis | Baldness | Frontal-parietal thinning | Hair loss | Hair thinning | Other alopecia | Body hair loss | Traction alopecia | Alopecia post chemotherapy | Anterolateral leg alopecia | Hair Loss | Hair Losses | Loss, Hair | Losses, Hair | Alopecia, Male Pattern | Male Pattern Alopecia | Baldness, Male Pattern | Male Pattern Baldness | Female Pattern Baldness | Baldness, Female Pattern | Androgenetic Alopecia | Pattern Baldness | Baldness, Pattern | Androgenic Alopecia | Alopecia, Androgenic | Alopecias, Androgenic | Androgenic Alopecias | Alopecia, Androgenetic | Pseudopelade | Alopecia Cicatrisata | Alopecia Cicatrisatas
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02358Vinblastine--
BADD_D02359Vinblastine sulfate--
BADD_D02360Vincristine--
BADD_D02362Vinflunine--
BADD_D02363Vinorelbine--
BADD_D02364Vinorelbine tartrate--
BADD_D02365Vismodegib0.059266%
BADD_D02367Voltaren--
BADD_D02369Voriconazole--
BADD_D02370Vorinostat0.000246%
BADD_D02371Vortioxetine0.009208%
BADD_D02373Warfarin--
BADD_D02374Warfarin sodium--
BADD_D02378Zalcitabine--
BADD_D02379Zaleplon--
BADD_D02389Ziprasidone hydrochloride--
BADD_D02391Ziprasidone mesylate--
BADD_D02392Zoledronic acid--
BADD_D02396Zonisamide0.001326%
BADD_D02401Coenzyme M0.000184%
BADD_D02412Octreotide0.001416%
BADD_D02428Loperamide--
BADD_D02440Lisdexamfetamine0.001794%
BADD_D02446Prasterone0.019169%
BADD_D02456Vilazodone0.005367%
BADD_D02463Pitavastatin0.002102%
BADD_D02464Fingolimod0.057602%
BADD_D02470Nintedanib--
BADD_D02472Sonidegib0.001063%
BADD_D02482Acalabrutinib--
The 24th Page    First    Pre   24 25    Next   Last    Total 25 Pages